A project to develop a new antitumor drug for the treatment of breast cancer has been launched at the Moscow Institute of Physics and Technology (MIPT), with a timeline set for three years. The ...

Moscow Mayor Sergei Sobyanin announced the launch of new medicine production in the capital, as reported by the press service of the metropolitan mayor. In 2024, the turnover of the capital’s ...

The Khoroshevsky interdistrict investigative Department of the Investigative Department for the Northwestern Administrative District of the Main Investigative Department of the Investigative Committee ...

Scientists at Sirius University of Science and Technology have developed and patented a new way to combat obesity using gene therapy methods, Kommersant writes with reference to the press service of ...

The Russian government has reorganized FMBA’s Federal State Unitary Enterprise “Federal Center for Design and Development of Nuclear Medicine Facilities”, transforming it into a federal state ...

Russian scientists have proposed a new method for evaluating the effectiveness of photosensitizers —compounds that destroy cancer cell membranes when exposed to light — which is expected to accelerate ...

Scientists at Tomsk Polytechnic University (TPU) have developed and patented Russia’s first theranostic pair—original radiopharmaceuticals for the diagnosis and therapy of prostate cancer. The TPU ...

DALKHIMPHARM has begun manufacturing Loxoprofen for the Russian market, a generic version of Loxonin (INN Loxoprofen), the most prescribed non-steroidal anti-inflammatory drug (NSAID) in Japan noted ...

The total volume of pharmacy sales of medicines and dietary supplements of the Russian pharmaceutical company Binnopharm Group in 2024 exceeded 48 billion rubles, the press service of the company ...

A new industrial-type special economic zone (SEZ), Bolshoy Serpukhov, will be established in the Moscow Region, as a resolution prepared by the Ministry of Economic Development was approved by the ...

Major pharmaceutical manufacturers have expressed their opposition to the creation of the List of Strategically Important Drugs, arguing that it duplicates the existing list of vital and essential ...

Russia has approved regulations governing the circulation of personalized biotechnological drugs, known as individualized biotechnology derived medications, according to a government resolution ...